Simplex Trading
AXSM icon

Simplex Trading’s Axsome Therapeutics AXSM Stock Holding History

Simplex Trading’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.03M Buy
17,900
+2,500
+16% +$432K ﹤0.01% 1494
2025
Q4 		$2.81M Sell
15,400
-39,900
-72% -$5.57M ﹤0.01% 1708
2025
Q3 		$6.72M Buy
55,300
+6,000
+12% +$676K ﹤0.01% 1224
2025
Q2 		$5.15M Sell
49,300
-11,900
-19% -$1.26M ﹤0.01% 1322
2025
Q1 		$7.14M Sell
61,200
-104,400
-63% -$11.9M ﹤0.01% 1085
2024
Q4 		$14M Buy
165,600
+115,300
+229% +$10.6M 0.01% 829
2024
Q3 		$4.52M Buy
50,300
+4,000
+9% +$349K ﹤0.01% 1566
2024
Q2 		$3.73M Sell
46,300
-16,100
-26% -$1.19M ﹤0.01% 1643
2024
Q1 		$4.98M Buy
62,400
+25,200
+68% +$2.12M ﹤0.01% 1608
2023
Q4 		$2.96M Buy
37,200
+4,400
+13% +$294K ﹤0.01% 2020
2023
Q3 		$2.29M Sell
32,800
-36,200
-52% -$2.71M ﹤0.01% 1958
2023
Q2 		$4.96M Sell
69,000
-27,400
-28% -$2.02M ﹤0.01% 1325
2023
Q1 		$5.95M Sell
96,400
-88,700
-48% -$5.83M 0.01% 1188
2022
Q4 		$14.3M Buy
185,100
+86,900
+88% +$5.19M 0.02% 699
2022
Q3 		$4.38M Sell
98,200
-21,900
-18% -$1.09M 0.01% 1290
2022
Q2 		$4.6M Buy
120,100
+60,700
+102% +$1.92M ﹤0.01% 1200
2022
Q1 		$2.46M Sell
59,400
-7,800
-12% -$242K ﹤0.01% 1893
2021
Q4 		$2.54M Buy
67,200
+61,800
+1,144% +$2.27M ﹤0.01% 1787
2021
Q3 		$368K Hold
5,400
– – ﹤0.01% 4566
2021
Q2 		$364K Buy
5,400
+5,313
+6,107% +$319K ﹤0.01% 4649
2021
Q1 		$492K Buy
+87
New +$6.12K ﹤0.01% 3401
2020
Q2 		– Sell
-701
Closed -$4.12M – 7583
2020
Q1 		$4.12M Sell
701
-351
-33% -$28.6K 0.01% 802
2019
Q4 		$10.9M Buy
1,052
+885
+530% +$35.7K 0.02% 436
2019
Q3 		$338K Sell
167
-205
-55% -$5.27K ﹤0.01% 3049
2019
Q2 		$957K Sell
372
-508
-58% -$10.2K ﹤0.01% 1943
2019
Q1 		$1.25M Buy
+880
New +$8.17K ﹤0.01% 1799

Other funds holding AXSM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Simplex Trading's AXSM Position: Q1 2026 in Review

Simplex Trading sold out of Axsome Therapeutics (AXSM) in Q1 2026, closing a stake of 25,222 shares — an estimated $4.36M sold.

Simplex Trading first reported a position in AXSM in Q3 2018 and held it in 28 quarters. The position peaked at $4.61M in Q4 2025. 409 funds tracked by Wall St. Rank hold AXSM as of Q1 2026.

  • Simplex Trading reported no remaining Axsome Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Simplex Trading sold 25,222 Axsome Therapeutics shares in Q1 2026, an estimated $4.36M.
  • Simplex Trading first reported a position in Axsome Therapeutics in Q3 2018 and held it in 28 quarters.
  • Simplex Trading's Axsome Therapeutics position peaked at $4.61M in Q4 2025.
  • 409 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.